Studies on the purification of antihemophilic factor (factor VIII): I. Precipitation Of Antihemophilic Factor By Concanavalin A

AUTOR(ES)

Kass, Lawrence

RESUMO

Concanavalin A precipitates antihemophilic factor from normal plasma. Combining this precipitation with other techniques, we were able to separate fractions rich in antihemophilic activity from human plasma with rapidity. The molecular weight of antihemophilic factor was estimated to be greater than 2 million. Presumably, antihemophilic factor is a large glycoprotein.

Documentos Relacionados

• Studies on the purification of antihemophilic factor (factor VIII): II. Separation of partially purified antihemophilic factor by gel filtration of plasma
• Studies on the Nature of Antihemophilic Factor (Factor VIII): FURTHER EVIDENCE RELATING THE AHF-LIKE ANTIGENS IN NORMAL AND HEMOPHILIC PLASMAS
• Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).
• Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease: With observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor
• The Immunologic Character of Acquired Inhibitors of Antihemophilic Globulin (Factor VIII) and the Kinetics of Their Interaction with Factor VIII*